Document ID: chunk:federal_register_of_legislation:C2025C00156:section:106u:p3
Version: federal_register_of_legislation:C2025C00156
Segment Type: section
Provision Reference: s 106U (pt 3/3)
Character Range: 560208–562064

for any of the services included in the class.
 (2A) A direction under paragraph (1)(f) must specify a period of suspension of up to 3 years, to start when the determination takes effect.
 (3) For the purposes of paragraphs (1)(g) and (h), the period specified must not be more than:
 (a) if the person under review is a practitioner in relation to whom an agreement under section 92, or a final determination under section 106TA, has previously taken effect—5 years; or
 (b) in any other case—3 years.
 (4) This section applies as if a reference in this section to a practitioner included a reference to a person who has been a practitioner.
 (5) In this section:
associated person, in relation to a person under review, means:
 (a) an employee of the person under review; or
 (b) a person otherwise engaged by the person under review; or
 (c) an employee of a body corporate of which the person under review is an officer; or
 (d) a person otherwise engaged by a body corporate of which the person under review is an officer.
Part VII authority means any of the following authorities or approvals under Part VII of the National Health Act 1953:
 (a) the authority conferred upon a medical practitioner by section 88 of that Act;
 (b) the approval of a dental practitioner as a participating dental practitioner under section 84A of that Act;
 (ba) the approval of an optometrist as an authorised optometrist under section 84AAB of that Act;
 (bb) the approval of an eligible midwife as an authorised midwife under section 84AAF of that Act;
 (bc) the approval of an eligible nurse practitioner as an authorised nurse practitioner under section 84AAJ of that Act;
 (c) the approval of a medical practitioner under section 92 of that Act;
 (d) the authority conferred upon a medical practitioner by section 93 of that Act to supply pharmaceutical benefits.